Study of a new drug for post-traumatic stress disorder
Part of Mental health clinical trials.
This study tests a new medication, TSND-201, to see if it is safe and effective for people living with PTSD. It is for adults who have already tried at least one other treatment and are looking for a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with PTSD for at least 6 months
- You have tried at least one medication or trauma-focused therapy for PTSD
- You can communicate well in English (both speaking and reading)
- You do not have any other major medical conditions
- Your body mass index (BMI) is between 18 and 40
- You can go without nicotine for at least 8 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.
This trial checks the long-term safety and how well TSND-201, a study drug, helps people with PTSD. It is for patients who already completed a previous TSND-201 study and did well.
This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.
This study tests whether a stimulant medication can help reduce PTSD symptoms. If you have PTSD and are generally healthy, you might be able to join.
This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.
This study tests a new oral medication called PT150 to see if it helps reduce PTSD symptoms in Veterans. Participation involves taking the medication, regular check-ups, and questionnaires.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.